13F filing recap · Q3 2022
What did ARK Invest buy in Q3 2022?
Reported stock-position changes between this filing and the previous one. US-listed stocks across every ARK-managed account, including accounts that belong to no fund below.
Stock value
$14.34B
Positions
235
Estimated turnover
25.0%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
New positions
SLGCUSDSomalogic Inc$31.95Mreported value+11.02M sharesGHGuardant Health, Inc.$29.18Mreported value+542.1K sharesMRNAModerna, Inc.$19.34Mreported value+163.6K sharesXPNGFXpeng Inc.$5.17Mreported value+883.0K sharesSNTISenti Biosciences Holdings, Inc.$4.53Mreported value+2.09M sharesCMPSCompass Pathways Plc$4.17Mreported value+388.6K sharesHUBCHub Cyber Security Ltd.$2.14Mreported value+1.40M sharesMLCompagnie Generale Des Etablissements Michelin Sca$1.89Mreported value+83.5K sharesSAMHFAlleima Ab$8.0Kreported value+2.7K shares